Gemini Therapeutics, Inc. (GMTX) at a glance

Gemini Therapeutics, Inc. (GMTX) is a company. It trades at $70.79. It does not pay a dividend. Vestovix scores it 52/100 overall. Its strongest dimension is Safety (66/100) and its weakest is Income (40/100).

Price

$70.79

Market cap

n/a

P/E ratio

n/a

Dividend yield

None

Beta

n/a

52-week range

$40.00 to $99.50